Arrhythmias in the neonatal period are not uncommon, and may occur in neonates with a normal heart or in those with structural heart disease. Neonatal arrhythmias are classified as either benign or nonbenign. Benign arrhythmias include sinus arrhythmia, premature atrial contraction, premature ventricular contraction, and junctional rhythm; these arrhythmias have no clinical significance and do not need therapy. Supraventricular tachycardia, ventricular tachycardia, atrioventricular conduction abnormalities, and genetic arrhythmia such as congenital long-QT syndrome are classified as nonbenign arrhythmias. Although most neonatal arrhythmias are asymptomatic and rarely life-threatening, the prognosis depends on the early recognition and proper management of the condition in some serious cases. Precise diagnosis with risk stratification of patients with nonbenign neonatal arrhythmia is needed to reduce morbidity and mortality. In this article, I review the current understanding of the common clinical presentation, etiology, natural history, and management of neonatal arrhythmias in the absence of an underlying congenital heart disease.
Introduction
Arrhythmias in the neonatal period are not uncommon, and may occur in neonates with a normal heart or in those with structural heart disease. The incidence of neonatal arrhythmia is reported to be 1%-5% in all neonates [1] [2] [3] . The clinical manifestation is variable. Neonatal arrhythmias are classified as either benign or nonbenign. Benign arrhythmias include sinus arrhythmia, premature atrial contraction (PAC), premature ventricular contraction (PVC), and junctional rhythm; these arrhythmias have no clinical significance and do not need therapy. Supraventricular tachycardia (SVT), ventricular tachycardia (VT), atrioventricular (AV) conduction abnormalities, and genetic arrhythmias such as congenital long-QT syndrome (LQTS) are classified as nonbenign arrhythmias [1] [2] [3] [4] [5] . Congenital heart disease (CHD) not only affects the anatomical defect but also causes electrical changes, that induce various arrhythmias. In addition, surgical correction may also be related to the cause of arrhythmia in patients with CHD. Previous studies reported that arrhythmic substrates predispose patients to CHD-related arrhythmia, and the clinical manifestations and treatment differ between patients with a normal heart and those with CHD. In this article, I review the current understanding of the common clinical presentations, etiology, natural history, and management of neonatal arrhythmias in patients without underlying CHD.
Premature atrial contractions
PACs are common in the neonatal period and manifest as irregular heartbeats. In a previous study, PACs were detected on Holter electrocardiogram (ECG) in 51% of normal newborns 6) . A premature P wave superimposed on the previous T wave can cause deformation of the T wave. Nonconduction of PACs can some times occur and be misdiagnosed as sinus bradycardia in neonatal intensive care units. The QRS morphology is similar to that of sinus rhythm. However, the aberrant conduction of PACs causes a different QRS morphology (Fig. 1) . Isolated PACs in neonates are associated with electrolyte abnormalities, hypoglycemia, hypoxia, and hyperthyroidism. PACs are generally benign and usually do not need treatment 5) .
Premature ventricular contractions
PVCs are relatively uncommon compared with PACs in the fetal and neonatal periods. In a previous study, PVCs were detected on Holter ECG in 18% of normal neonates 6) . In PVCs, there is no preceding P wave and premature QRS complex showing different morphology from sinus rhythm (Fig. 2) .
Ventricular arrhythmia may occur in CHD, cardiomyopathy, inflammatory myocardial disease, metabolic disease, electrolyte disturbance and LQTS 7, 8) . However, the immaturity of cardiac conduction tissue and the autonomic nerve system may be the main causes of frequent premature beats in newborns 5) . Isolated PVCs usually spontaneously resolve, and no treatment is required in neonates with a normal heart 5, 7) . In the quantitative assessment of PVCs, frequent PVCs are defined as >60 beats/hr in a child 8) . Although PVC burden is significantly Fig. 1 . Premature atrial complexes. A premature and unrecognized P wave occurs with the previous T wave, and the QRS complex has a similar morphology to the sinus rhythm. This indicates premature atrial complexes (arrows). The asterisk indicates aberrant ventricular conduction. associated with ventricular dysfunction in adults, asymptomatic frequent PVCs in newborns have a good long-term prognosis 8) .
Neonatal tachyarrhythmias

Supraventricular tachycardias
SVT is the most common type of tachyarrhythmia observed in pediatric patients, especially in the neonatal period. SVT is defined as tachycardia resulting from an abnormal mechanism involving the heart structures proximal to the bifurcation of the bundle of His, and that does not have the morphology of atrial flutter (AFL) on the surface ECG. SVT is classified into 2 types; real SVT and atrial tachycardia. Real SVT includes accessory pathwayrelated AV reentrant tachycardia (AVRT), AV nodal reentrant tachycardia (AVNRT), permanent form of junctional reciprocating tachycardia (PJRT), and junctional ectopic tachycardia (JET). The mechanism of tachycardia is associated with reentry, automaticity enhancement, and triggered activity. The most common mechanism is reentry. Accessory pathway-related AVRT, AVNRT, and PJRT can be classified as reentry tachycardias. Another mechanism of tachycardia is increased automaticity, which includes sinus tachycardia, ectopic atrial tachycardia (EAT), and JET. A rare mechanism of tachycardia is triggered activity, which includes atrial fibrillation (AF) 4, 5, [9] [10] [11] .
1) Atrioventricular reentrant tachycardia
Accessory pathway-related AVRT is commonly associated with Wolff-Parkinson-White (WPW) syndrome in neonates. WPW syndrome is defined as a congenital condition involving an abnormal electrical conduction of the accessory pathway. The accessory pathway connecting impulses between the atrium and the ventricle can be seen at any site in the AV groove. Interestingly, the presence of WPW was seen only in term infants, not in preterm infants, and it may account for differences in the clinical course between preterm and term infants 12) . AVRT is initiated paroxysmally with PACs and terminates with AV block. There are 2 different mechanisms of accessory pathwayrelated reentrant SVT. The usual reentrant circuits for AVRT are the AV node for anterograde conduction and the accessory pathway for retrograde conduction (called "orthodromic" AVRT). During tachycardia, a narrow QRS complex with a retro grade P wave immediately following QRS is seen on the ECG (Fig. 3) . Less commonly, "antidromic" tachycardia is the other mechanism of AVRT. Antergrade AV conduction occurs over the accessory pathway and retrograde conduction occurs over the AV node. In this case, a wide-complex rhythm may be observed.
Adenosine triphosphate is the first choice of drug for acute termination of AVRT, and the mechanism of the drug is related to AV node block 13) . To prevent recurrence, antiarrhythmic prophylaxis is recommended during the first year of life. Digoxin or propranolol is generally considered as the initial antiarrhythmic therapy. In a recent study, there was no difference in AVRT recurrence in infants <4 months old treated with an initial therapy of digoxin versus those treated with propranolol 14) . In case of failure of these first-line drugs, class IA (procainamide or quinidine), class IC (flecainide), or class III (amiodarone or sotalol) drugs can be considered 15) .
2) Atrioventricular nodal reentrant tachycardia
AVNRT is uncommon in small children, occurring in up to 3%-13% of infants with SVT. The reentrant circuit involves the fast pathway, which enters the compact AV node from the anterior tenance therapy with antiarrhythmic drugs and radiofrequency catheter ablation are always required.
4) Ectopic atrial tachycardia
EAT has relevance to increased automaticity of the atria. It shows an abnormal P wave axis with incessant tachycardia. Therefore, "warm-up" and "cool-down" phenomena can be observed. It usually shows 1:1 AV conduction, although a variable ventricular rate is also possible (Fig. 4) . This tachycardia may not be responsive to adenosine or DC cardioversion. Moreover it can be resistant to antiarrhythmic drugs. EAT can lead to tachycardia-induced cardiomyopathy if not properly controlled 17, 18) . The combination of flecainide and amiodarone or flecainide and sotalol or high-dose septal region close to the compact AV node, and the slow pathway, which is located in the posterior septal region. In the common type of AVNRT, anterograde conduction occurs down the slow pathway and retrograde conduction occurs up the fast pathway 11) .
3) Permanent form of junctional reciprocating tachycardia
PJRT is a less common form of AVRT with a slow conducting retrograde accessory pathway. It presents with long RP tachycardia with inverted P waves in the inferior leads (II, III, and aVF). The typical characteristics are incessant tachycardia and slower ventricular rate (about 200 beats/min) than in other tachycardias 16) . Adenosine transiently terminates PJRT, which usually recurs after adenosine or direct current (DC) cardioversion. Therefore, main- sotalol therapy can control refractory SVT in infants [19] [20] [21] . In addition, younger patients (<3 years old) are more likely to respond to antiarrhythmic therapy and have a high incidence of EAT resolution than children ≥3 years old 22) .
5) Junctional ectopic tachycardia
JET is also characterized by incessant tachycardia with a single ectopic focus initiating at or near the AV node. It usually shows AV dissociation with an atrial slower than the ventricular rate (Fig. 5) . The ventricular rate often ranges between 160 beats/min to as high as 280 beats/min. The mechanism of tachycardia is related to the enhanced automaticity of the AV junction. JET is usually observed in postoperative patients with CHD within the first several days after cardiopulmonary bypass. JET not associated with cardiac surgery is a rare arrhythmia in newborns. Congenital JET is highly associated with morbidity and mortality in neonates 23, 24) . Patents presenting symptoms at age <6 months are more likely to have incessant JET; however, patient outcomes considerably improve with amiodarone therapy, permanent pacing, radiofrequency catheter ablation, and cryoablation, although congenital JET remains difficult to treat 25) .
Atrial flutter
AFL is characterized by saw-tooth flutter waves with an atrial rate of up to 500 beats/min, and is frequently associated with 2:1 AV conduction in neonates (Fig. 6A) . Variable AV conduction is also common. The mechanism of AFL is macroreentry within the atrial wall.
AV block does not terminate AFL because the AV node is not involved the reentrant circuit. For this reason, adenosine cannot terminate AFL but unmasks the flutter wave by causing AV block (Fig. 6B) . Fetal AFL can cause hydrops fetalis or fetal heart fail ure. After birth, AFL is usually treated with DC cardioversion or transesophageal pacing in patients with hemodynamically unstable AFL. In some patients with AFL, antiarrhythmic therapy such as digoxin and propranolol can be used as maintenance therapy. Although refractory AFL is a critical condition in neonates, recurrence of AFL is uncommon and long-term drug therapy is rarely required 26, 27) .
Ventricular tachycardias
Wide QRS complex tachycardias should be assumed to be VT in pediatric patients. However, SVT with aberrancy, SVT with the presence of an underlying bundle branch block or ventricular preexcitation, or SVT in an antidromic tachycardia circuit can result in wide QRS complex tachycardias.
VT is rare in the neonatal period. It is defined as three or more PVCs in a row at a rate faster than 120 bpm/min and has a wide QRS com plex with AV dissociation during the tachycardia. Capture beats or fusion beats are diagnostic markers in VT (Fig. 7) . Nonsustained VT is defined as three or more consecutive PVCs with a duration of <30 seconds. The possible cause of VT may be associated with myocarditis, cardiac tumor, CHD, hereditary cardiomyopathy, LQTS, and electrolyte abnormalities in neonates. Idiopathic VT is defined as VT without an identified underlying cause 28, 29) . There are 2 benign forms of VT according to the bundle branch block pattern of QRS morphology that suggests the origin of VT; right ventricular outflow tract VT (left bundle branch block pattern with inferior axis) and idiopathic fascicular VT (right bundle branch block pattern QRS morphology with superior axis). The initial selection of the drug is rather different. In patients with idiopathic fascicular VT, verapamil is the first-choice antiarrhythmic drug. The mechanism of VT is reentry within the posterior fascicle of the left ventricle. In case of right ventricular outflow tract VT, beta-blocker is the first-choice drug. The assumed mechanism of VT is triggered activity 30) . If hemodynamically unstable VT develops, DC cardioversion should be performed. However, intravenous lidocaine can be administered in patients with hemodynamically stable VT.
Neonatal bradyarrhythmias
Sinus bradycardia
Sinus bradycardia is defined as a sinus rate slower than normal for age, and is frequently detected in the neonatal intensive unit. Transient sinus bradycardia in newborns is benign and usually resolves within 48-72 hours. Furthermore, it may occur after a stressful labor or delivery. In premature babies, apnea is associated with intermittent bradycardia. Sinus bradycardia is mostly associated with general condition abnormalities such as hypoxia, acidosis, hypoglycemia, and increased intracranial pressure 4, 5, 10) . Therefore, physicians should make an effort to find the etiology and treat the underlying cause. Fig. 7 . Ventricular tachycardia. A wide QRS compex with right bundle branch block pattern ventricular tachycardia is shown. A high ventricular rate of 270 beats/min is dissociated from the atrial rate (arrows). A capture beat (asterisks), which is completely conducted by the sinus beat, is a hallmark of ventricular tachycardia. Fig. 8 . Complete atrioventricular block. The atrial rate is 150 beats/ min and the wide QRS complex ventricular rate is 55 beats/min. The atrioventricular (AV) dissociation (arrows) with slow ventricular rate indicates complete heart block. The escape beats may be ventricular in origin because the QRS complex is wide and bizarre.
AV dissociation
Complete AV block
AV block is defined as a conduction disturbance of an impulse from the atria to the ventricle and classified as either first-, second-, or third-degree (or complete) AV block. Among these types, complete AV block of the AV node results in AV dissociation between atrial and ventricular activity. There is no relationship between the P wave and QRS complexes (Fig. 8) . Ventricular escape rhythm can occur anywhere from the AV node to the Purkinje system.
Congenital complete AV block in a normal structural heart may occur in infants born to mothers with connective tissue disorders such as systemic lupus erythematosus. This accounts for 90% of the cases. The maternal autoimmune antibody crosses the placenta and damages the AV node of the fetus 31, 32) . Among cases of congenital complete AV block, only 10% are considered idiopathic heart block 33) . Recently, it has been recognized that the prognosis of con genital complete AV block differs depending on whether the block is identified in a fetus, newborn, or older child 32, 33) . Permanent pacemaker implantation is indicated in newborns or infants with complete heart block with a ventricular rate of <55 beats/min or in those with CHD and a ventricular rate of <70 beats/ min. Another indication is complete heart block with a wide complex escape rhythm, complex ventricular ectopy, or ventricular dysfunction 34) .
Genetic arrhythmias
Cardiac channelopathy represents arrhythmic conditions related to mutations in genes encoding the critical ion channels of the heart. It includes congenital LQTS, short-QT syndrome (SQTS), catecholaminergic polymorphic VT (CPVT), and Brugada syndrome.
Long-QT syndrome
Congenital LQTS is a channelopathy due to a gene mutation of the ion channel associated with ventricular repolarization. It presents with syncope and sudden cardiac death, and is characterized by polymorphic VT or torsades de pointes (Fig. 9A) . Approximately 75% of clinically definite LQTS cases are caused by mutations in three genes: KCNQ1 (LQT1), KCNH2 (LQT2), and SCN5A (LQT3). To date, ≥600 mutations have been identified in 14 LQTS-susceptibility genes [35] [36] [37] . During the neonatal period, congenital LQTS is usually diagnosed with QT prolongation combined with sinus bradycardia or 2:1 AV block (Fig. 9B ) 38) . Moreover, a beta-blocking agent is considered the initial therapy in newborns. In congenital LQTS, implantable cardioverter defibrillator (ICD) implantation is recommended for patients with a family history of sudden death, intolerance to medication, or recurrent syncope on full doses of a betablocker 34) .
Catecholaminergic polymorphic VT
CPVT is characterized by exercise-or stress-induced syncope or sudden death. Patients have CPVT have a family history of juvenile sudden death. CPVT clinically mimics LQTS but is much Korean J Pediatr 2017;60(11):344-352 more malignant than concealed LQTS. The age at presentation can vary from infancy to 40 years. The hallmark ECG feature of CPVT is exercise-or isoproterenol-induced ventricular arrhythmia, particularly bidirectional VT. Beta-blocker is first therapy for patients with symptomatic CPVT 39, 40) .
Short-QT syndrome
Patients with SQTS present with sudden death, syncope, palpitation and paroxysmal AF.
Sudden death occurs in patients aged from 3 months to 70 years. The characteristic ECG finding is a short QT interval (QTc≤330 ms), with tall, symmetrical, peaked T waves. Most patients have potential ventricular fibrillation. The therapy of choice is ICD implantation. Furthermore, adjunctive antiarrhythmic therapy with propafenone, quinidine, dofetilide, or sotalol may decrease the risk for ventricular fibrillation 41, 42) .
Conclusion
The most common benign arrhythmia in newborns is PAC, which does not require treatment. AVRT, which is the most frequent tachyarrhythmia in neonates can be properly controlled with antiarrhythmic drug therapy. Complete AV block is the most common cause of nonbenign bradyarrhythmia, for which permanent pacemaker implantation should be performed. Although the frequency of nonbenign arrhythmias is not high, the prognosis depends on the early recognition and proper management of the condition in some serious neonatal cases. Precise diagnosis with risk stratification of patients with nonbenign neonatal arrhythmia is needed to reduce morbidity and mortality.
